ESC Premium Access

Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Event: ESC CONGRESS 2019
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Satellite Symposium
Supported by an unrestricted educational grant from AstraZeneca
Date: 3 September 2019
Time: 13:00 - 14:00

Session

6 presentations in this session

Welcome and introduction

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

The prothrombotic nature of diabetes

Speaker: Professor K. Ray (London, GB)
Thumbnail

Current practice of dual antiplatelet therapy in patients with diabetes

Speaker: Professor H. Darius (Berlin, DE)
Thumbnail

Recent data and future direction on dual antiplatelet therapy in patients with diabetes

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Discussion

Speaker: Doctor M. Bonaca (Aurora, US)
Speaker: Professor H. Darius (Berlin, DE)
Speaker: Professor K. Ray (London, GB)
Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Summary and close

Speaker: Doctor M. Bonaca (Aurora, US)
Thumbnail

9 speakers from this session

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48 presentations
1 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
24 presentations
0 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48 presentations
1 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
24 presentations
0 follower

This platform is supported by

logo Novo Nordisk